Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review...
Health Qual Life Out. 2014 Jul 3; 12: 102.
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Ann. Rheum. Dis. 2004 Sep 1; 63 (9): 1062-8.
Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome.
J Rheumatol. 2013 May 1; 40 (5): 743-4.